This analysis synthesizes 10 sources published the week ending Oct 19, 2026. Editorial analysis by the PhysEmp Editorial Team.
Median total cash compensation for presidents and CEOs of health system-owned medical groups climbed 7.9% to 9.6% between 2025 and 2026, according to SullivanCotter survey data. Over that same stretch, pay in 17 of 30 clinical specialties lagged behind the 3.4% rise in consumer prices through August, and five specialties saw cash earnings drop outright. Both figures come from the same health systems over the exact same twelve months. Performance didn’t cause the divide—track assignment did.
That split is the most consequential development in Physician Compensation & Demand this year. Clinical production pay is being ground down by fee schedule mechanics that compound through 2027, while pay for roles tied to clinical integration and enterprise growth surges at double-digit rates. The real bargaining chip in a 2026 employment agreement isn’t where the base salary lands on the percentile charts. It’s the title, and the protected administrative FTE carved out behind it.
Where the Raise Actually Came From
Medical group executives didn’t get their bump through base salary. Median base pay for physician CEOs ticked up 4.9% to $697,400, and 3.5% to $560,600 for non-physicians. The real money arrived as incentive pay: the spread between total cash and base pay widened 19% for physician CEOs (landing near $205,000) and 36% for non-physicians (hitting $170,000). Since those incentive payouts rewarded 2025 financial performance, the surge was a retrospective reward for past operational numbers, not a permanent structural commitment.
Nor is the physician premium itself expanding. Physician CEOs pulled in a median $902,400 compared to $730,400 for non-physician peers—a $172,000 spread (around 24%) that remained essentially flat in dollar terms year over year. What actually grew was the roster of seats. Health systems expanded the size and operational footprint of their physician networks, running headlong into a genuine bottleneck: plenty of doctors can fill an operating room schedule, but very few carry the administrative credibility to govern several hundred colleagues. That scarcity commands the $172,000 premium. Delivering it via incentive dollars rather than base simply ensures a health system can pull it back the moment margins tighten.
Repricing the Clinical Ladder
On the clinical side, the math has curdled. CMS clipped work RVUs by 2.5% across roughly 7,700 non-time-based codes on Jan. 1, touching 91% of physician services by billed volume. For 2026, a modest conversion factor bump softened the hit for those billing Medicare directly, but employed physicians working under straight wRVU contracts had no cushion. Unless an employer explicitly froze 2025 RVU values, identical work produced fewer units overnight. Run SullivanCotter’s median dollar-per-wRVU conversion rates against the cut: diagnostic radiologists lose roughly 260 wRVUs ($13,260 a year); orthopedic surgeons drop 160 wRVUs ($11,200); interventional cardiologists lose about $8,340. Family medicine loses zero.
The proposed 2027 fee schedule drops whatever cover was left. The baseline conversion factor falls from $33.4009 to $32.8409—a 1.68% nominal reduction, translating to an average 2.2% drop in reimbursement that reaches as deep as 3.6% in Arkansas and Southern Maine. Specific specialties take direct hits: dermatology and ENT face an estimated 9% cut, driven by CMS’ plan to pay only 50% for secondary same-day services billed under modifier 25. Orthopedic surgery faces a 7% drag, powered by a proposed 20% RVU reduction for total knee and hip replacements. Behavioral health runs in the opposite direction—clinical social work gains 12% and clinical psychology 11%.
That regulatory shift matches the inflation numbers almost point for point. Psychiatry notched a 5.1% real gain after inflation and infectious disease gained 3.8%, while cardiology (-3.1%), plastic surgery (-3.1%), otolaryngology (-4.2%), and hepatology (-12.7%) slipped backward. High-earning procedural fields—orthopedics averaging $801,071 and radiology at $690,809—are losing real purchasing power fastest. A wRVU-pegged contract offer in late 2026 is essentially a depreciating asset: candidates signing today agree to fixed unit rates on production volume that CMS is actively pruning, with another recalculation slated for 2029 and H.R. 7520 stalled in committee.
Why Stipends Follow Regulators, Not Ambition
Administrative pay exists, but it is heavily rationed. Roughly one in 14 full-time physicians (7.1%) receives a leadership stipend, typically around $25,000, or 5% of their total pay. Those checks concentrate almost exclusively where external regulations compel them: emergency medicine tops the list at $70,500 (13.5% of total pay), followed by hematology-oncology ($56,500) and physical medicine and rehabilitation ($55,700). Clinic-bound specialists rarely see a dime—allergy sits at 0.9% and dermatology at 3.6%. If an accrediting body or statute requires a director’s signature, hospitals fund the position. If not, the work is volunteered.
Getting into those roles is heavily seniority-gated. A mere 1.6% of physicians in their first two years of practice receive a stipend, compared to 11.8% of those fifteen to twenty years in. That seniority barrier directly frustrates early-career doctors who want guaranteed cash rather than production upside as annual base salary growth flattens to 2% to 4%.
There is also a structural trap here. Every administrative dollar pulls a doctor out of a market governed by an open, predictable Medicare fee schedule and drops them into one dictated by an internal compensation committee. A public fee schedule cuts painfully, but it does so in daylight. Internal administrative pay is discretionary, untracked by public surveys, and almost impossible to benchmark when leadership changes or negotiations turn contentious.
What the Title Costs, and Why $500K Stops Closing
“Medical director” has no statutory definition, which makes the role easy to negotiate and surprisingly perilous to hold. Administrative obligations carry genuine operational exposure: drafting clinical policies, overseeing staff training, and sitting on CMS-mandated quality review panels. Standard clinical malpractice policies regularly exclude administrative decisions, forcing physicians to rely on separate errors and omissions coverage. Because directorships are one of the few legal avenues for hospitals to funnel compensation to specialists, regulatory auditors expect every billed administrative hour to be logged in detail. The liability isn’t hypothetical; a Texas anesthesiologist who agreed to serve as medical director for an off-site med spa faces criminal charges following a patient fatality that occurred while he was 100 miles away, with his medical license restricted in the interim.
Against that backdrop, a $500,000 salary offer has lost its power to close. Starting pay already clears that benchmark in gastroenterology ($654,000), urology ($638,000), radiology ($571,000), cardiology ($568,000), anesthesiology ($525,000), and orthopedics ($507,000), with signing bonuses baked into 87% of recruitments at an average of $49,306. Yet half of all searches sat unfilled at the end of 2025—urology filled just 28.3% of openings, with the median recruitment dragging out 119 days to an offer and 229 days to an actual start date. Quoted per-wRVU rates for identical clinical work swing between $36 and $95. Compensation remains the first concession health systems offer when physicians disengage, yet it fails to touch the core friction: 91% of physicians cite autonomy as a primary priority, while only 59% say they have any.
Watch the November final rule to see if CMS backs off the modifier 25 haircut that 85% of commenters opposed, and whether Congress steps in before government funding expires Dec. 11. If the policy survives intact, dermatology and ENT groups will spend the spring renegotiating conversion multipliers and RVU floors across their current deals. At the same time, health system boards running a median subsidy of $315,358 per employed physician will have to decide whether to write another check or quietly jack up the RVU targets for the doctors still seeing patients.
Sources
Why medical group leaders are seeing big leaps in pay – Modern Healthcare
Medical group CEO pay climbs as health systems grow physician enterprises – Becker’s Hospital Review
Physician CEOs earn $172K more than non-MD peers – Becker’s Physician Leadership
Physician specialties ranked by leadership pay – Becker’s Physician Leadership
The hidden liability risks of medical director roles – Becker’s Physician Leadership
The wRVU efficiency cut, in dollar terms – Becker’s Physician Leadership
Which physicians are losing the most ground to inflation? – Becker’s Physician Leadership
The proposed 2027 Medicare physician pay cuts, by specialty – Becker’s Physician Leadership
Why $500K isn’t enough to recruit some physicians: 10 notes – Becker’s Physician Leadership
Why raising physician pay doesn’t always solve burnout – Medical Economics